Company profile for Tiburio Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Dedicated to advancing novel treatments for rare neuroendocrine tumors and rare endocrine diseases Our pipeline consists of two clinical stage compounds, TBR-760 for the treatment of non-functioning pituitary adenoma (NFPA) and TBR-065 for additional rare endocrine diseases. We were launched out of orphan drug accelerator Cydan with financing from leading life science investors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
700 Technology Square, 2nd Floor Cambridge, MA 02139 USA
Telephone
Telephone
+1 617.231.6050
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Natural Products Expo

Natural Products Expo

Not Confirmed

envelop Contact Supplier

Natural Products Expo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2020/05/11/2031192/0/en/Tiburio-Announces-Publication-of-Preclinical-TBR-760-Data-in-Non-Functioning-Pituitary-Adenoma-in-Journal-of-the-Endocrine-Society.html

GLOBENEWSWIRE
11 May 2020
Startup Tiburio nabs Avrobio executive Kreher as CMO
Startup Tiburio nabs Avrobio executive Kreher as CMO

13 Mar 2019

// Ben Adams FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/startup-tiburio-nabs-avrobio-exec-kreher-as-chief-medical-officer

Ben Adams FIERCE BIOTECH
13 Mar 2019

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty